The ABX PENTRA Cholesterol CP ref. A11A01634 is an in vitro diagnostic assay for quantitative det...
FDA Device Recall #Z-0738-2016 — Class II — January 11, 2016
Recall Summary
| Recall Number | Z-0738-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 11, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Horiba Instruments Inc |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 216 |
Product Description
The ABX PENTRA Cholesterol CP ref. A11A01634 is an in vitro diagnostic assay for quantitative determination of cholesterol in human serum and plasma based on an enzymatic photometric test (Trinders reaction). The assay is composed of a 99 ml mono-reagent cassette. Reagent is a chemical solution with additives.
Reason for Recall
N-Acetylcysteine (NAC) present in the blood of patients treated for paracetamol overdose can interfere with the Trinder reaction that uses hydrogen peroxide catalytic on aminoantipyrine and phenol, and can produce falsely low results with the reagents using the Trinder reaction method.
Distribution Pattern
U.S. distribution to the following; CA, NY, AL, OK, MN, MS, MD, TX, KY, WV, MT, IL, FL, VA, WA, MI, KS, NE, PA, OH, ID, OR, AR, AZ, NM, NC, SC, GA, TN No foreign distribution.
Lot / Code Information
All Lots
Other Recalls from Horiba Instruments Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1554-2016 | Class II | Pentra C400 (version 1.1.2 or lower) The ABX... | Feb 19, 2016 |
| Z-1553-2016 | Class II | ABX Pentra 400 (version 5.0.8 or lower) The ... | Feb 19, 2016 |
| Z-0740-2016 | Class II | ABX PENTRA Glucose PAP CP ref. A11A01668 reage... | Jan 11, 2016 |
| Z-0742-2016 | Class II | ABX PENTRA Triglycerides CP ref. A11A01640 is a... | Jan 11, 2016 |
| Z-0743-2016 | Class II | ABX PENTRA Uric Acid CP ref. A11A01670 is an i... | Jan 11, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.